The Board has remanded the claims for service connection for pituitary adenoma, right facial disorder, and Sjogren's syndrome due to additional evidence submitted after the issuance of the June 2021 Supplemental Statement of the Case (SSOC).
The deciding factor: Additional medical evidence was submitted after the SSOC, which requires further development by the AOJ.
- Claimed conditions
- pituitary adenoma, right facial disorder, Sjogren's syndrome
- How they argued it
- Not specified
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- December 14, 2021
- Citation
- 21074225
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 21074225.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Partly granted
Service connection for rheumatoid arthritis and Sjogren's syndrome is granted.,Service connection for hypertension is remanded due to insufficient evidence regarding its onset in service or as a result of a disease or injury in active service.
- Whole decision: Remanded (sent back)
The Veteran's pituitary adenoma is being remanded for a VA examination to determine if it is related to his exposure to contaminated water at Camp Lejeune. The PACT Act requires this examination and opinion, but was not in effect when the initial decision was made.
- Whole decision: Granted
The Veteran's service-connected conditions, including lupus and Sjogren's syndrome, were granted. The rating for Raynaud's disease was restored to a lower level, and the effective dates for TDIU and DEA were established.
- Whole decision: Dismissed
The Board has dismissed the appeals for increased rating for Raynaud's disease and service connection for Sjogren's syndrome as the appellant withdrew her appeal prior to a decision.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.